222 related articles for article (PubMed ID: 28382874)
21. Visual working memory deterioration preceding relapse in psychosis.
Hui CL; Li YK; Li AW; Lee EH; Chang WC; Chan SK; Lam SY; Thornton AE; Sham P; Honer WG; Chen EY
Psychol Med; 2016 Aug; 46(11):2435-44. PubMed ID: 27305830
[TBL] [Abstract][Full Text] [Related]
22. Adolescent vs. adult onset of a first episode psychosis: Impact on remission of positive and negative symptoms.
Veru F; Jordan G; Joober R; Malla A; Iyer S
Schizophr Res; 2016 Jul; 174(1-3):183-188. PubMed ID: 27102425
[TBL] [Abstract][Full Text] [Related]
23. Improvement in verbal learning over the first year of antipsychotic treatment is associated with serum HDL levels in a cohort of first episode psychosis patients.
Gjerde PB; Simonsen CE; Lagerberg TV; Steen NE; Ueland T; Andreassen OA; Steen VM; Melle I
Eur Arch Psychiatry Clin Neurosci; 2020 Feb; 270(1):49-58. PubMed ID: 31028479
[TBL] [Abstract][Full Text] [Related]
24. [Risperidone in the early treatment of first-episode psychosis: a two-year follow-up study].
Gutiérrez Fraile M; Segarra Echevarría R; González-Pinto Arrillaga A; Martínez Junquera G
Actas Esp Psiquiatr; 2002; 30(3):142-52. PubMed ID: 12106515
[TBL] [Abstract][Full Text] [Related]
25. Prospective relationship between duration of untreated psychosis and 13-year clinical outcome: a first-episode psychosis study.
Tang JY; Chang WC; Hui CL; Wong GH; Chan SK; Lee EH; Yeung WS; Wong CK; Tang WN; Chan WF; Pang EP; Tso S; Ng RM; Hung SF; Dunn EL; Sham PC; Chen EY
Schizophr Res; 2014 Mar; 153(1-3):1-8. PubMed ID: 24529612
[TBL] [Abstract][Full Text] [Related]
26. Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review.
Zipursky RB; Menezes NM; Streiner DL
Schizophr Res; 2014 Feb; 152(2-3):408-14. PubMed ID: 23972821
[TBL] [Abstract][Full Text] [Related]
27. Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocol.
Weller A; Gleeson J; Alvarez-Jimenez M; McGorry P; Nelson B; Allott K; Bendall S; Bartholomeusz C; Koval P; Harrigan S; O'Donoghue B; Fornito A; Pantelis C; Paul Amminger G; Ratheesh A; Polari A; Wood SJ; van der El K; Ellinghaus C; Gates J; O'Connell J; Mueller M; Wunderink L; Killackey E
Early Interv Psychiatry; 2019 Dec; 13(6):1345-1356. PubMed ID: 30488637
[TBL] [Abstract][Full Text] [Related]
28. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
29. Should Antipsychotic Medications for Schizophrenia Be Given for a Lifetime?: A Naturalistic, Long-Term Follow-Up Study.
Glick ID; Davis JM; Zamora D; Ballon J; Nuthi M
J Clin Psychopharmacol; 2017 Apr; 37(2):125-130. PubMed ID: 28195931
[TBL] [Abstract][Full Text] [Related]
30. Five-fold increased risk of relapse following breaks in antipsychotic treatment of first episode psychosis.
Winton-Brown TT; Elanjithara T; Power P; Coentre R; Blanco-Polaina P; McGuire P
Schizophr Res; 2017 Jan; 179():50-56. PubMed ID: 27745754
[TBL] [Abstract][Full Text] [Related]
31. Predicting 1-year risk for relapse in patients who have discontinued or continued quetiapine after remission from first-episode psychosis.
Hui CL; Wong GH; Tang JY; Chang WC; Chan SK; Lee EH; Lam MM; Chiu CP; Law CW; Chung DW; Tso S; Pang EP; Chan KT; Wong YC; Mo FY; Chan KP; Hung SF; Honer WG; Chen EY
Schizophr Res; 2013 Oct; 150(1):297-302. PubMed ID: 23993865
[TBL] [Abstract][Full Text] [Related]
32. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.
Castro-Fornieles J; Parellada M; Soutullo CA; Baeza I; Gonzalez-Pinto A; Graell M; Paya B; Moreno D; de la Serna E; Arango C
J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):327-36. PubMed ID: 18759642
[TBL] [Abstract][Full Text] [Related]
33. Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era.
Alvarez-Jimenez M; O'Donoghue B; Thompson A; Gleeson JF; Bendall S; Gonzalez-Blanch C; Killackey E; Wunderink L; McGorry PD
CNS Drugs; 2016 May; 30(5):357-68. PubMed ID: 27106296
[TBL] [Abstract][Full Text] [Related]
34. Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors.
Demjaha A; Lappin JM; Stahl D; Patel MX; MacCabe JH; Howes OD; Heslin M; Reininghaus UA; Donoghue K; Lomas B; Charalambides M; Onyejiaka A; Fearon P; Jones P; Doody G; Morgan C; Dazzan P; Murray RM
Psychol Med; 2017 Aug; 47(11):1981-1989. PubMed ID: 28395674
[TBL] [Abstract][Full Text] [Related]
35. Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis. A systematic review.
Bowtell M; Ratheesh A; McGorry P; Killackey E; O'Donoghue B
Schizophr Res; 2018 Jul; 197():9-18. PubMed ID: 29146020
[TBL] [Abstract][Full Text] [Related]
36. Predicting relapse after a first episode of non-affective psychosis: a three-year follow-up study.
Caseiro O; Pérez-Iglesias R; Mata I; Martínez-Garcia O; Pelayo-Terán JM; Tabares-Seisdedos R; Ortiz-García de la Foz V; Vázquez-Barquero JL; Crespo-Facorro B
J Psychiatr Res; 2012 Aug; 46(8):1099-105. PubMed ID: 22721546
[TBL] [Abstract][Full Text] [Related]
37. Psychotic Symptoms and Attitudes toward Medication Mediate the Effect of Insight on Personal-Social Functions in Patients with Schizophrenia: One-Year Randomized Controlled Trial and Follow-Up.
Zheng Y; Ning Y; She S; Deng Y; Chen Y; Yi W; Lu X; Chen X; Li J; Li R; Zhang J; Xiao D; Wu H; Wu C
Psychopathology; 2018; 51(3):167-176. PubMed ID: 29444522
[TBL] [Abstract][Full Text] [Related]
38. Treatment and violent behavior in persons with first episode psychosis during a 10-year prospective follow-up study.
Langeveld J; Bjørkly S; Auestad B; Barder H; Evensen J; Ten Velden Hegelstad W; Joa I; Johannessen JO; Larsen TK; Melle I; Opjordsmoen S; Røssberg JI; Rund BR; Simonsen E; Vaglum P; McGlashan T; Friis S
Schizophr Res; 2014 Jul; 156(2-3):272-6. PubMed ID: 24837683
[TBL] [Abstract][Full Text] [Related]
39. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
[TBL] [Abstract][Full Text] [Related]
40. The Effect of Substance Use on 10-Year Outcome in First-Episode Psychosis.
Weibell MA; Hegelstad WTV; Auestad B; Bramness J; Evensen J; Haahr U; Joa I; Johannessen JO; Larsen TK; Melle I; Opjordsmoen S; Rund BR; Simonsen E; Vaglum P; McGlashan T; McGorry P; Friis S
Schizophr Bull; 2017 Jul; 43(4):843-851. PubMed ID: 28199703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
